Skip to main content
. 2021 Apr 20;70(10):3041–3053. doi: 10.1007/s00262-021-02938-z

Table 4.

Association between characteristics of patients and pericardial disease outcome

Characteristics Outcome P
Grade at the onset Improvement rate*, % (n/N)
 G4 (n = 16) 68.8% ( 11/16) 1.000
 ≤ G3 (n = 11) 72.2% ( 8/ 11)
Best response to ICI Improvement rate, % (n/N)
 CR/PR (n = 15) 66.7% (10/15) 1.000
 SD/PD (n = 5) 80.0% ( 4/ 5)
Other irAEs Improvement rate, % (n/N)
 Yes (n = 11) 90.9% ( 10/11) 0.191
 No (n = 17) 64.7% ( 11/17)
Malignant effusion Improvement rate, % (n/N)
 Yes (n = 7) 42.8% ( 3/ 7) 0.053
 No (n = 15) 86.7% (13/15)
Pericardiocentesis/drainage/window Improvement rate, % (n/N)
 Yes (n = 21) 76.2% (16/21) 1.000
 No (n = 7) 71.4% ( 5/ 7)
Steroid therapy Improvement rate, % (n/N)
 Yes (n = 15) 86.7% (13/15) 0.197
 No (n = 13) 61.5% ( 8/13)
Discontinuation of ICI Improvement rate, % (n/N)
 Yes (n = 18) 72.2% ( 13/18) 1.000
 No (n = 6) 66.7% ( 4/ 6)
Rechallenge of ICI Recurrence rate, % (n/N)
 Yes (n = 7) 0% ( 0/ 7) 0.521
 No (n = 11) 18% ( 2/ 11)

*Improvement rate defined as rate of patients with full or partial recovery of pericardial disease, with no evidence of recurrence; recurrence rate defined as rate of patients with initial resolution/improvement of pericardial disease, followed by recurrent/worsening pericardial disease